China-Biotics (CHBT) Expects Q311 Revs Stronger than Street Views
China-Biotics, Inc. (Nasdaq: CHBT) announced the following preliminary results.
Sees Q311 revs of $32 - $33 million, versus the consensus of $31.27 million.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Sees Q311 revs of $32 - $33 million, versus the consensus of $31.27 million.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Monro Muffler (MNRO) Tops Q4 EPS by 1c; Comps About Flat; Guides FY13 EPS Below Views
- UPDATE: NetApp, Inc. (NTAP) Tops Q4 EPS by 3c; Guides Q1 Lower
- Pandora (P) Blows Up Expectations as Listener Hours Rip; Guides FY13 Ahead of Views
Create E-mail Alert Related Categories
GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
